Is asymptomatic surveillance beneficial after standard treatment? A 10‐year survival analysis of recurrent BC patients by detection method of recurrence.

MLA

Lee, Han Shin, et al. “Is Asymptomatic Surveillance Beneficial after Standard Treatment? A 10‐year Survival Analysis of Recurrent BC Patients by Detection Method of Recurrence.” Breast Journal, vol. 26, no. 3, Mar. 2020, pp. 556–59. EBSCOhost, https://doi.org/10.1111/tbj.13603.

APA

Lee, H. S., Kim, J., Chung, I. Y., Ko, B. S., Kim, H. J., Lee, J. W., Son, B. H., Ahn, J., Jung, K. H., Kim, S., Lee, H. J., Gong, G., Ahn, S. H., & Lee, S. B. (2020). Is asymptomatic surveillance beneficial after standard treatment? A 10‐year survival analysis of recurrent BC patients by detection method of recurrence. Breast Journal, 26(3), 556–559. https://doi.org/10.1111/tbj.13603

Chicago

Lee, Han Shin, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, et al. 2020. “Is Asymptomatic Surveillance Beneficial after Standard Treatment? A 10‐year Survival Analysis of Recurrent BC Patients by Detection Method of Recurrence.” Breast Journal 26 (3): 556–59. doi:10.1111/tbj.13603.